marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Pluristem Therapeutics Financial Ratios 2011-2024 | PSTI
Annual Financial Ratios Pluristem Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.3 | -0.2 | -0.8 | -0.6 | -5.7 | -2.0 | -5.0 | -3.7 | -5.1 | -6.8 | -6.7 | -7.9 | -9.9 | -9.9 |
P/S |
16.6 | 16.4 | 141.7 | - | 7239.4 | 1279.0 | 2604.6 | - | 41.4 | 439.5 | 477.6 | 247.6 | 204.8 | - |
EPS |
-4.0 | -6.2 | -1.3 | -1.8 | -1.6 | -2.9 | -2.5 | -3.2 | -0.3 | -0.3 | -0.4 | -0.4 | -0.3 | -0.3 |
EV (Enterprise Value) |
-1.39 M | -641 K | 23.4 M | -3.13 M | 168 M | 74.4 M | 132 M | 106 M | 119 M | 154 M | 188 M | 170 M | 147 M | 66.8 M |
EBITDA per Share |
-4.18 | -5.87 | -1.26 | -1.75 | -1.53 | -2.72 | -3 | -2.96 | -2.66 | -3.3 | -4.09 | -3.82 | -3.31 | -3.46 |
EV/EBITDA |
0.1 | -5.7 | -1.9 | -3.8 | -3.8 | -5.3 | -6.2 | -6.8 | -7.5 | -7.9 | -5.9 | |||
PEG |
-0.0 | -0.0 | 0.06 | 0.11 | -0.13 | 0.12 | -0.23 | 0.36 | -0.3 | -0.41 | 0.64 | 0.68 | -3.47 | -0.48 |
P/B |
0.1 | 0.1 | 0.5 | 0.3 | 3.0 | 3.2 | 4.6 | 3.4 | 3.1 | 2.9 | 2.9 | 2.9 | 3.9 | 2.5 |
P/CF |
-0.3 | -0.2 | -0.9 | -0.9 | -6.3 | -2.3 | -6.0 | -4.7 | -5.8 | -7.8 | -8.7 | -7.9 | -30.8 | -15.9 |
ROE % |
-21758.33 | -212.06 | -137.29 | -87.25 | -51.96 | -161.80 | -91.65 | -91.94 | -60.92 | -42.44 | -43.35 | -36.81 | -39.20 | -24.98 |
ROA % |
-52.84 | -55.75 | -60.59 | -53.31 | -44.49 | -112.77 | -67.06 | -74.10 | -50.60 | -36.21 | -36.38 | -30.97 | -31.20 | -23.57 |
ROCE % |
-74.47 | -63.02 | -70.39 | -61.72 | -51.22 | -153.47 | -110.91 | -87.23 | -58.06 | -40.77 | -41.80 | -35.62 | -35.88 | -25.26 |
Current Ratio |
- | - | - | - | 6.1 | 3.2 | 3.7 | 5.4 | 6.2 | 9.2 | 8.4 | 9.3 | 6.9 | 21.5 |
DSO |
- | - | 14.8 | - | 25550.0 | 9604.9 | 6183.1 | - | 318.1 | 2415.4 | 2179.4 | - | 172.3 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
126655.0 | 72939.2 | - | - | - | 416282.5 | 595132.5 | - | 9873.2 | 91755.4 | 114975.0 | 51775.2 | - | - |
Operating Cycle |
- | - | 14.8 | - | - | 9604.9 | 6183.1 | - | 318.1 | 2415.4 | 2179.4 | - | - | - |
Cash Conversion Cycle |
-126655.0 | -72939.2 | 14.8 | - | - | -406677.6 | -588949.4 | - | -9555.2 | -89340.0 | -112795.6 | -51775.2 | - | - |
All numbers in USD currency
Quarterly Financial Ratios Pluristem Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.08 | - | -0.12 | -0.96 | - | -0.19 | -0.24 | -0.19 | -0.44 | -0.31 | -0.34 | -0.36 | -0.7 | -0.48 | -0.49 | -0.33 | -0.49 | -0.33 | -0.4 | -0.46 | -0.4 | -0.46 | -0.75 | -0.77 | - | -0.01 | -0.08 | -0.08 | -0.08 | -0.08 | -0.08 | -0.08 | -0.08 | -0.08 | -0.05 | -0.07 | -0.05 | -0.07 | -0.09 | -0.09 | -0.09 | -0.09 | -0.11 | -0.08 | -0.11 | -0.08 | -0.08 | -0.08 | -0.08 | -0.08 | -0.05 | -0.11 | -0.05 | -0.11 |
EBITDA per Share |
-0.94 | - | - | -1.03 | - | - | -0.2 | -0.21 | -0.41 | -0.32 | -0.34 | -0.35 | -0.67 | -0.48 | -0.51 | -0.33 | -0.48 | -0.33 | -0.4 | -0.44 | -0.35 | -0.44 | -0.72 | -0.74 | - | -0.08 | -0.08 | -0.07 | -0.07 | -0.07 | -0.08 | -0.07 | -0.07 | -0.07 | -0.05 | -0.06 | -0.04 | -0.06 | -0.09 | -0.07 | -0.08 | -0.07 | -0.11 | -0.07 | -0.1 | -0.07 | -0.08 | -0.08 | - | -0.09 | - | -0.1 | -0.05 | -0.1 |
ROE % |
-156.61 | -196.44 | -236.43 | -157.44 | -95.26 | -142.66 | -127.24 | -122.19 | -122.81 | -114.55 | -114.92 | -117.97 | -111.94 | -103.30 | -95.70 | -105.23 | -132.76 | -142.29 | -165.68 | -182.79 | -195.74 | -160.31 | -124.19 | -89.30 | -57.18 | -79.45 | -105.15 | -109.21 | -98.12 | -102.17 | -91.08 | -72.79 | -64.79 | -46.50 | -38.51 | -43.19 | -42.97 | -47.65 | -47.44 | -45.75 | -43.42 | -41.73 | -39.40 | -34.88 | -31.74 | -27.22 | -29.13 | -27.56 | -33.18 | -31.61 | -32.17 | -11.15 | -4.94 | -11.15 |
ROA % |
-51.34 | -36.49 | -50.05 | -51.79 | -37.34 | -58.26 | -57.17 | -57.10 | -60.51 | -63.51 | -66.28 | -76.83 | -77.58 | -72.82 | -70.53 | -72.13 | -83.63 | -84.81 | -94.66 | -104.77 | -107.31 | -90.53 | -71.29 | -53.96 | -45.82 | -67.74 | -83.85 | -85.92 | -77.79 | -70.26 | -64.35 | -50.95 | -44.97 | -36.39 | -31.25 | -34.88 | -34.40 | -37.02 | -36.39 | -35.08 | -33.08 | -34.46 | -33.44 | -5698.96 | -5696.60 | -5686.80 | -5688.26 | -13.34 | -17.45 | -21.77 | -23.11 | -9.01 | -4.33 | -9.76 |
ROCE % |
-63.59 | -42.82 | -57.29 | -54.54 | -39.35 | -62.37 | -62.58 | -65.44 | -68.38 | -72.47 | -75.12 | -90.98 | -92.65 | -96.24 | -96.23 | -100.94 | -123.39 | -129.63 | -150.45 | -163.62 | -176.17 | -164.96 | -152.54 | -125.48 | -75.89 | -97.70 | -100.33 | -103.28 | -93.70 | -96.40 | -86.84 | -70.36 | -61.38 | -44.82 | -35.85 | -39.48 | -39.35 | -43.15 | -42.98 | -41.76 | -40.17 | -39.06 | -37.53 | -33.97 | -31.34 | -20.82 | -22.69 | -15.66 | -19.83 | -24.89 | -25.49 | -9.67 | -5.17 | -10.60 |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 565.4 | - | 108.6 | 1083.6 | - | - | 179.8 | - | 1890.7 | - | - | 43.1 | - | - | 9.4 | 1013.4 | 56.1 | 888.0 | 292.5 | 1303.4 | 2173.7 | 1086.8 | - | 131.1 | 747.8 | 617.5 | 390.7 | 390.4 | 89701.8 | 151.8 | 96977.8 | 112.3 | 60.8 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
757.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 171686.9 | - | - | 216581.9 | 117963.4 | 208141.2 | - | 95949.4 | 123050.6 | - | - | 76672.8 | - | 89698.8 | - | - | 2278.1 | - | - | 1566.3 | 72437.3 | 3074.3 | 88056.2 | 56381.1 | 89516.2 | 79045.3 | 93926.7 | 85029.8 | 86946.0 | 86292.1 | 43197.7 | 12922.5 | 12907.1 | 10412902.5 | 19329.8 | 14665178.6 | 20558.6 | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 565.4 | - | 108.6 | 1083.6 | - | - | 179.8 | - | 1890.7 | - | - | 43.1 | - | - | 9.4 | 1013.4 | 56.1 | 888.0 | 292.5 | 1303.4 | 2173.7 | 1086.8 | - | 131.1 | 747.8 | 617.5 | 390.7 | 390.4 | 89701.8 | 151.8 | 96977.8 | 112.3 | 60.8 | - |
Cash Conversion Cycle |
-757.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -171686.9 | - | - | -216581.9 | -117963.4 | -207575.9 | - | -95840.8 | -121967.0 | - | - | -76493.1 | - | -87808.1 | - | - | -2235.0 | - | - | -1556.9 | -71423.9 | -3018.2 | -87168.2 | -56088.6 | -88212.8 | -76871.6 | -92839.8 | -85029.8 | -86814.9 | -85544.3 | -42580.2 | -12531.8 | -12516.7 | -10323200.7 | -19177.9 | -14568200.8 | -20446.3 | 60.8 | - |
All numbers in USD currency